Ormeloxifene treatment inhibits growth of cisplatin-resistant ovarian cancer cells

被引：0
|
作者：
Nordquist, Jordan [1 ,2 ]
Maher, Diane M. [1 ]
Ebeling, Mara [1 ]
Jaggi, Meena [1 ,3 ,4 ]
Chauhan, Subhash C. [1 ,3 ,4 ]
机构：
[1] Sanford Res USD, Canc Biol Res Ctr, Sioux Falls, SD USA
[2] Univ S Dakota, Sanford Sch Med, Sioux Falls, SD USA
[3] Univ S Dakota, Sanford Sch Med, Dept OB GYN, Sioux Falls, SD USA
[4] Univ S Dakota, Sanford Sch Med, Basic Biomed Sci Div, Sioux Falls, SD USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-4521
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4521
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells
    Amani I. Moraya
    Jennifer L. Ali
    Pranati Samadder
    Lisa Liang
    Ludivine Coudière Morrison
    Tamra E. Werbowetski-Ogilvie
    Makanjuola Ogunsina
    Frank Schweizer
    Gilbert Arthur
    Mark W. Nachtigal
    Journal of Experimental & Clinical Cancer Research, 36
  • [32] TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
    Liu, Yixuan
    Zhu, Keyu
    Guan, Xiaolin
    Xie, Suhong
    Wang, Yanchun
    Tong, Ying
    Guo, Lin
    Zheng, Hui
    Lu, Renquan
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [33] TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
    Yixuan Liu
    Keyu Zhu
    Xiaolin Guan
    Suhong Xie
    Yanchun Wang
    Ying Tong
    Lin Guo
    Hui Zheng
    Renquan Lu
    Journal of Ovarian Research, 14
  • [34] Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B
    El-Senduny, Fardous F.
    Badria, Farid A.
    EL-Waseef, Ahmed M.
    Chauhan, Subhash C.
    Halaweish, Fathi
    TUMOR BIOLOGY, 2016, 37 (01) : 685 - 698
  • [35] Glutathione S-transferase π immunostaining of cisplatin-resistant ovarian cancer cells in ascites
    Kase, H
    Kodama, S
    Nagai, E
    Tanaka, K
    ACTA CYTOLOGICA, 1998, 42 (06) : 1397 - 1402
  • [36] High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin-resistant ovarian cancer cells
    Prasad, Mona
    Bernardini, Marcus
    Tsalenko, Anya
    Marrano, Paula
    Paderova, Jana
    Lee, Chung-Hae
    Ben-Dor, Amir
    Barrett, Michael T.
    Squire, Jeremy A.
    GENES CHROMOSOMES & CANCER, 2008, 47 (05): : 427 - 436
  • [37] Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells
    Moraya, Amani I.
    Ali, Jennifer L.
    Samadder, Pranati
    Liang, Lisa
    Morrison, Ludivine Coudiere
    Werbowetski-Ogilvie, Tamra E.
    Ogunsina, Makanjuola
    Schweizer, Frank
    Arthur, Gilbert
    Nachtigal, Mark W.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [38] Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells
    Wan, XS
    Hamilton, TC
    Ware, JH
    Donahue, JJ
    Kennedy, AR
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1998, 31 (01): : 8 - 17
  • [39] Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells
    Zhang, Ruitao
    Shi, Huirong
    Ren, Fang
    Li, Xia
    Zhang, Minghui
    Feng, Wei
    Jia, Yanyan
    ONCOLOGY REPORTS, 2016, 35 (04) : 2466 - 2472
  • [40] RESTORATIVE EFFECTS OF CALMODULIN ANTAGONISTS ON REDUCED CISPLATIN UPTAKE BY CISPLATIN-RESISTANT HUMAN OVARIAN-CANCER CELLS
    KIKUCHI, Y
    IWANO, I
    MIYAUCHI, M
    SASA, H
    NAGATA, I
    KUKI, E
    GYNECOLOGIC ONCOLOGY, 1990, 39 (02) : 199 - 203
12345